The first clinical/translational data from the expansion cohorts of a Ph1/1b study of IPI-549, a tumor macrophage-reprogramming small molecule, in combination with nivolumab in advanced solid tumors Meeting Abstract
| Authors: | Chmielowski, B.; Sullivan, R. J.; Postow, M.; Patnaik, A.; Shapiro, G.; Cohen, E.; Gutierrez, M.; Steuer, C.; Ribas, A.; Lee, L.; O'Connell, B.; Kutok, J.; Roberts, J.; Mahabhashyam, S.; Fjallskog, M. L.; Wolchok, J. D.; Hong, D. |
| Abstract Title: | The first clinical/translational data from the expansion cohorts of a Ph1/1b study of IPI-549, a tumor macrophage-reprogramming small molecule, in combination with nivolumab in advanced solid tumors |
| Meeting Title: | 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 6 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2018 Nov 7-11 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2018-12-06 |
| Start Page: | 434 |
| Language: | English |
| DOI: | 10.1186/s40425-018-0434-7 |
| PROVIDER: | manual |
| PMCID: | PMC6282247 |
| Notes: | Meeting Abstract: P716 |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work